Evolus
EOLS
165 hedge funds and large institutions have $815M invested in Evolus in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 21 closing their positions.
200% more call options, than puts
Call options by funds: $2.55M | Put options by funds: $851K
46% more capital invested
Capital invested by funds: $557M → $815M (+$257M)
43% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 21
36% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 42
6% more funds holding
Funds holding: 156 → 165 (+9)
2.28% less ownership
Funds ownership: 82% → 79.72% (-2.3%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$4.96M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$4.22M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$3.71M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.61M |
| 5 |
BlackRock
New York
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$17.9M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.9M |
| 3 |
Morgan Stanley
New York
|
-$6.71M |
| 4 |
PA
Perceptive Advisors
New York
|
-$5.55M |
| 5 |
CCM
Cutter Capital Management
New York
|
-$5.05M |
EOLS Hedge Fund Activity: Q3 2024 in Review
165 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q3 2024, worth a combined $815M — up 46% from $557M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new EOLS positions and 21 closed out — a net gain of 9 holders — while 57 added to existing stakes and 42 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $4.96M. The largest seller was Great Point Partners, cutting an estimated $17.9M.
- 165 institutional investors held Evolus (EOLS) as of Q3 2024, up from 156 in Q2 2024.
- Funds reported $815M of Evolus stock for Q3 2024, up 46% quarter-over-quarter.
- 30 funds opened new Evolus positions in Q3 2024 and 21 closed out, a net change of +9 holders.
- The largest Evolus buyer in Q3 2024 was Altium Capital Management, an estimated $4.96M added.
- The largest Evolus seller in Q3 2024 was Great Point Partners, an estimated $17.9M sold.
Based on aggregated 13F filings for Q3 2024.